RE: Total void of any reference to...That's simply because the whole Urocidin project is in Endo's hand now. BNC by contractual agreement cannot make any pr in reference to Urocidin before Endo.
At the mean time, BNC has no money to doing anything with the MCC platform on other applications which require mega-bucks until they get the pay-off on Urocidin's revenue from its sales. That's why they are canning the whole human trial section and put an animal health guy in charge for now.
For any news on Urocidin in the near future, we might as well go to the Endo board!